Start Your Search
MS19 - New Health Technology for Lung Cancer; Assessment and Implementation (ID 36)
- Event: WCLC 2013
- Type: Mini Symposia
- Track: Radiation Oncology + Radiotherapy
- Presentations: 1
- Moderators:Y. Lievens, F.(. Kong
- Coordinates: 10/30/2013, 14:00 - 15:30, Parkside Ballroom B, Level 1
MS19.2 - Cost Effectiveness of Prevention of Lung Cancer (Developed and Developing World) (ID 547)
14:00 - 15:30 | Author(s): A. Hutson
Abstract not provided
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.
P3.23 - Poster Session 3 - Tobacco Control, Prevention and Chemoprevention (ID 164)
- Event: WCLC 2013
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 1
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
P3.23-004 - Thoracic oncology providers and addressing tobacco use in cancer patients: a report from an IASLC survey. (ID 2047)
09:30 - 16:30 | Author(s): A. Hutson
Background: Tobacco use increases toxicity, recurrence, second primary cancers, and mortality in cancer patients. However, oncologists do not routinely provide assistance with tobacco cessation and little is known about potential barriers that could be addressed to improve cessation practices among oncologists.
Methods: An online survey was sent to IASLC members querying demographics, tobacco assessment and cessation practices, perceptions of tobacco use by cancer patients, and barriers to tobacco cessation intervention. Results are reported and multivariate analyses were performed to identify likely barriers to tobacco assessment and cessation.
Results: A total of 1,507 IASLC members responded to the survey representing a 40.5% response rate. Most respondents reported that tobacco use affected cancer outcome (92%) and that tobacco cessation should be a standard part of cancer care (90%). However, whereas 90% indicated that they regularly asked about tobacco use, only about 40% regularly discussed medications or provided cessation assistance. A lower likelihood of assessing tobacco use was associated with the following demographic variables: a) location outside of the United States (USA), b) practice non-academic centers, c) fewer years of service as a medical provider, d) less time spent on clinical activities, or e) current smoking. Variables associated with a decreased likelihood of giving advice to stop smoking were a) location outside of the USA and b) less time spent in clinic. A lower likelihood of providing cessation assistance was associated with providers outside of the USA. After adjustment for demographic variables, variables associated with increased likelihood of assessing tobacco use were a) providers who felt cessation affected outcome and b) providers who reported more training on cessation is needed. An increased likelihood to advise patients to stop smoking was observed in respondents who reported that additional cessation training is needed whereas a lack of time was reported as a variable that decreased likelihood to provide patient advice. Variables associated with a decreased likelihood to provide tobacco cessation assistance included: a) lack of time, b) lack of training, c) lack of available resources, and d) perception that tobacco cessation was a waste of time. However, variables associated with an increased likelihood to discuss medications or provide cessation assistance included respondents who a) reported having had adequate training in tobacco cessation or b) who reported that additional training is needed for clinicians.
Conclusions: Most IASLC member oncologists who responded to the survey asked about tobacco use, but few routinely provided tobacco cessation assistance to their patients. Cancer patients need increased access to tobacco cessation support. Differences in the measurements of perceived barriers suggest that efforts are needed to increase cessation resources and clinician education in order to improve tobacco cessation support for cancer patients.